| Sue Overturf, RN | |
|
715 N Saint Joseph Ave, Hastings, NE 68901-4451 | |
| (402) 461-5263 | |
| Not Available |
| Full Name | Sue Overturf |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 715 N Saint Joseph Ave, Hastings, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093734253 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 24097 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sue Overturf, RN 715 N Saint Joseph Ave, Hastings, NE 68901-4451 Ph: (402) 461-5263 | Sue Overturf, RN 715 N Saint Joseph Ave, Hastings, NE 68901-4451 Ph: (402) 461-5263 |
News Archive
Researchers have shown that despite effective combined antiretroviral therapy, HIV can hide in the spleen of patients with no detectable HIV in their blood.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, recently published a commentary in the American Journal of Medicine, about the benefits of statins in the prevention of heart attacks and strokes in subjects previously thought at too low a risk to be treated.
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Letrozole Tablets and will market the product with a period of exclusivity.
› Verified 2 days ago
Angela Shipman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 402-461-7578 Fax: 402-461-7509 | |
Mrs. Kelleen Redinger, B.S.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1824 Home St, Hastings, NE 68901 Phone: 402-834-0308 | |
Lorie L Berns, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 402-461-7578 Fax: 402-461-7509 | |
Tabitha Fox, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 402-461-7578 Fax: 402-461-7509 | |
Ella Clements, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-461-5263 | |
Sara Elizabeth Baumann, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1720 Crane Ave, Hastings, NE 68901 Phone: 402-461-7636 |